Recurrent Colon Carcinoma Completed Phase 1 Trials for Cetuximab (DB00002)

Also known as: Carcinoma colon recurrent / Colon carcinoma recurrent / Colon cancer recurrent

IndicationStatusPhase
DBCOND0047445 (Recurrent Colon Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01254617Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck CancerTreatment